Shannon T. Kelley, General Counsel at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 415 shares at $335.00 ($139K) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Scheduled sale ($139k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MDGL | SELL | 2026-01-20 | $344K | — | Filing → |
| MDGL | SELL | 2025-08-18 | $809K | — | Filing → |
| MDGL | SELL | 2025-01-17 | $151K | — | Filing → |